Construction and characterization of a novel secreted MsC-CAR-T cell in solid tumors
Cancer Letters · 2025
DOI: 10.1016/j.canlet.2024.217382 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Yuan Mao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China; National Health Commission Key Labora…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, CD47 Antigen, Receptors, Chimeric Antigen, Neoplasms. Die Arbeit nennt 80 Literaturangaben.
Abstract (Originalsprache)
The CD47-SIRPα signaling has been acknowledged as a significant immune checkpoint and CD47 blocking has been proved as a potential therapeutic strategy for the treatment of solid tumor. However, the potential application of CAR-T cells secreted antibody fragment simultaneously in solid tumor is rarely explored. In this study, we searched bioinformatic databases and investigated the characteristics of CD47 in solid tumors. Then we consulted bioinformatic databases to design, optimize and construct a novel MsC-CAR which could target MAGE-A1 and self-secrete CD47-scFv. The engineering T cells containing MsC-CAR were transfected, verified and characterized. The tumor-inhibitory role of MsC-CART cells was further determined in vitro and in vivo. The results showed that MsC-CARs were successfully constructed and MsC1-CARs demonstrated the preferable features of recognizing MAGE-A1 and secreting CD47-scFv. Engineering T cells transfecting with MsC1-CAR (MsC1-CART cells) exerted the prominent tumor-inhibitory effectiveness, both in different cancer cell lines and LUAD xenograft tumors. The present data highlighted that MsC1-CART cells elaborately combined the adoptive cellular immunotherapy and immune checkpoint inhibitor therapy, may represent a new direction for the treatment of MAGE-A1 positive solid tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China; National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, Chin…
- National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China; Department of Pathology, The Affiliated…
- National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China.
- National Health Commission Key Laboratory of Antibody Techniques, Nanjing Medical University, Nanjing, China; Department of Pathology, Nanjing Medical University, Nanjing, China; Jiangsu Province Engineering Research Ce…
- Department of Geriatric Oncology, The Fourth Affiliated Hospital of Nanjing Medical University, Nanjing, China.
- Department of Pathology, Changzhou No. 2 People's Hospital Affiliated with Nanjing Medical University, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, China.
Zitieren
APA
Mao, Y., Chen, Y., Yang, X., He, Y., Cui, D., Huang, W., Jiang, L., Zhou, X., Chang, X., Zhu, J., Zhu, Y., Tang, Q., Feng, Z., Zhang, L., Jiang, K., & Yuan, H. (2025). Construction and characterization of a novel secreted MsC-CAR-T cell in solid tumors. Cancer Letters. https://doi.org/10.1016/j.canlet.2024.217382
Vancouver
Mao Y, Chen Y, Yang X, He Y, Cui D, Huang W, et al. Construction and characterization of a novel secreted MsC-CAR-T cell in solid tumors. Cancer Letters. 2025. doi:10.1016/j.canlet.2024.217382
BibTeX
@article{Mao2025,
author = {Mao, Yuan and Chen, Yufeng and Yang, Xiaohui and He, Yiting and Cui, Daixun and Huang, Wen and Jiang, Lihua and Zhou, Xiaoli and Chang, Xinxia and Zhu, Jin and Zhu, Yi and Tang, Qi and Feng, Zhenqing and Zhang, Louqian and Jiang, Kuirong and Yuan, Hao},
title = {Construction and characterization of a novel secreted MsC-CAR-T cell in solid tumors},
journal = {Cancer Letters},
year = {2025},
doi = {10.1016/j.canlet.2024.217382}
}
EUVIMED